Posters & publications

You are here

Novosanis is developing the VAX-ID platform suited for accurate drug delivery of e.g. vaccines in the dermal layer of the skin.
Assessment of skin thickness in healthy adult volunteers
New prototype device for intradermal injection VAX-ID